🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: OGX-011 may kill tumor cells by blocking some of the proteins th...
Status
Completed
Location
Multiple Locations
Start Date
2003-04-04
Trial ID
NCT00471432
Treatments Being Tested
This Phase 3 study has been designed to confirm that adding custirsen to ca...
Status
Completed
Location
Prostate Oncology Specialists
Start Date
2012-08
Trial ID
NCT01578655
Treatments Being Tested
The purpose of this study is to determine if the addition of study drug (cu...
Status
Terminated
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01083615
Treatments Being Tested
This Phase 3 study has been designed to confirm that adding custirsen to st...
Status
Completed
Location
Teva Investigational Site 100
Start Date
2010-11
Trial ID
NCT01188187
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, wo...
Status
Completed
Location
University of Washington
Start Date
2005-09-28
Trial ID
NCT00258388
Treatments Being Tested
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Dru...
Status
Completed
Location
British Columbia Cancer Agency - Vancouver Cancer Centre
Start Date
2002-12-10
Trial ID
NCT00054106
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different...
Status
Completed
Location
British Columbia Cancer Agency - Centre for the Southern Interior
Start Date
2005-10-21
Trial ID
NCT00258375
Treatments Being Tested
This clinical study will help determine if giving OGX-011 (custirsen sodium...
Status
Completed
Location
LAC-USC Medical Center
Start Date
2004-11
Trial ID
NCT00138658
Treatments Being Tested
This is a 3-arm, parallel-group, active- and placebo-controlled, double-bli...
Status
Completed
Location
Teva Investigational Site 10565
Start Date
2013-05
Trial ID
NCT01874561
Treatments Being Tested